Skip to content
Search

Latest Stories

Welsh pharmacies start Covid-19 jabs pilot

Pharmacies in Wales have started to administer Covid-19 vaccines with a pilot starting in  Betsi Cadwaladr University Health Board on Friday (Jan 15).

Fferyllfa Llŷn Cyf in Llanbedrog, North Wales is the first in the country to offer the Oxford AstraZeneca vaccine from a pharmacy setting.


For the time-being, Welsh pharmacy sites are being piloted similar to how care homes were in the initial stages to establish the quickest, safest way to deliver vaccinations in these specific settings.

Local community pharmacies across the country are yet begin offering Covid-19 jabs as many of them may have on their mission to start their Covid-19 vaccination service.

Wales’s healthcare workforce are ‘coming together as one’ to ensure Wales’ Covid-19 vaccination programme rolls out as quickly as is safe to do, the Welsh Health Minister Vaughan Gething has said commenting on the launch of historic vaccination drive against the virus.

Gething said: “A mix of vaccination sites and centres have been selected to ensure everyone across the country has equal access to a vaccination. People can be expected to be asked to attend either a mass or community centre, hospital, GP practice, pharmacy or mobile unit.

“Just because there isn’t a type of service near to you, this does not mean any less is happening.

“Safety is of course at the fore of all that our Health Boards and staff do, but we have also worked to ensure our vaccination locations meet the needs of the characteristics of the vaccines and are as conveniently located as possible for the community it will serve.”

Appreciating the efforts taken by the community pharmacies for a mass Covid-19 vaccination drive, Gething added: “I cannot stress enough; your local health care workforce are doing absolutely everything they can, and to them I am immensely thankful.”

The minister further adviced the public on vaccination drive, “when it is your turn, you will be notified of where to go. Please do not call your GP or health services to request a Covid-19 vaccine and add undue pressure to their workloads.”

Pharmacist Llyr Hughes of Fferyllwyr Llŷn Cyf said: “We are incredibly proud to be the first pharmacy in Wales to roll out the Covid-19 vaccine and are keen to do all we can to support the Health Board and Welsh Government accelerate the roll out of the programme.

“Our aim is to work together with the Mass Vaccination Centres, GP practices and community pharmacies to deliver the largest vaccination programme the NHS has ever seen.

“Pharmacists play a huge role in vaccinating against flu on a yearly basis and have the skills and expertise to provide the new immunisations. I’m looking forward to seeing pharmacies across Wales play a big part in helping to protect our communities as the programme expands.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less